Skip to main content
SpringerLink
Log in

Topical Therapy in Uveitis

  • Chapter
  • First Online:
Treatment of Non-infectious Uveitis

  • 511 Accesses

Abstract

Topical pharmacotherapy is often the first-line treatment for the management of anterior uveitis and pseudophakic cystoid macular edema. It can be used to complement periocular and systemic therapy in ocular disease with posterior segment involvement. The vehicle of administration is either a drop or an ointment, and therapies can be subdivided into three categories: corticosteroids, cycloplegic agents, and nonsteroidal anti-inflammatory drugs (NSAIDs). This chapter will review common topical agents utilized in the management of acute and chronic anterior uveitis with an emphasis on mechanism of action, indications for use, side effects, and a review of evidence in support of their application.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gordon DM, McLean JM, Koteen H, Bousquet FP, McCusker WD, Baras I, et al. The use of ACTH and cortisone in ophthalmology. Am J Ophthalmol. 1951;34(12):1675–86.

    Article  CAS  Google Scholar 

  2. Becker B, Mills DW. Elevated intraocular pressure following corticosteroid eye drops. JAMA. 1963;185:884–6.

    Article  CAS  Google Scholar 

  3. Urban RC, Cotlier E. Corticosteroid-induced cataracts. Surv Ophthalmol. 1986;31(2):102–10.

    Article  CAS  Google Scholar 

  4. Awan MA, Agarwal PK, Watson DG, McGhee CN, Dutton GM. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophalmol. 2009;93(6):708–13.

    Article  CAS  Google Scholar 

  5. McGhee CN. Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol. 1992;76(11):681–4.

    Article  CAS  Google Scholar 

  6. Kragbelle K. Topical corticosteroids: mechanism of action. Acta Derm Venereol Suppl (Stockh). 1989;151:7–10.

    Google Scholar 

  7. Green K, Paterson CA, Cheeks L, Slagle T, Jay WM, Aziz MZ. Ocular blood flow and vascular permeability in endotoxin-induced inflammation. Ophthalmic Res. 1990;22:287–94.

    Article  CAS  Google Scholar 

  8. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. New Engl J Med. 2005;353(16):1711–23.

    Article  CAS  Google Scholar 

  9. Rosenblum C, Dengler RE, Geoffory RF. Ocular absorption of dexamethasone phosphate disodium b the rabbit. Arch Ophthalmol. 1967;77(2):234–7.

    Article  CAS  Google Scholar 

  10. Hosseini K, Matsushima D, Johnson J, Widera G, Nyam K, Kim L, et al. Pharmacokinetic study of dexamethasone disodium phosphate using intravitreal, subconjunctival, and intravenous delivery routes in rabbits. J Ocul Pharmacol Ther. 2008;24(3):301–8.

    Article  CAS  Google Scholar 

  11. Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM. Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol. 1988;106(5):686–7.

    Article  CAS  Google Scholar 

  12. Awan MA, Agarwal PK, Watson DG, McGhee CN, Dutton GN. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol. 2009;93(6):708–13.

    Article  CAS  Google Scholar 

  13. Sallam A, Sheth HG, Habot-Wilner Z, Lightman S. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Am J Ophthalmol. 2009;148(2):207–13.e1.

    Article  Google Scholar 

  14. Sallam A, Taylor SR, Lightman S. Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol. 2011;22(6):517–22.

    Article  Google Scholar 

  15. Slabaugh MA, Herlihy E, Ongchin S, van Gelder RN. Efficacy and potential complications of difluprednate use for pediatric uveitis. Am J Ophthalmol. 2012;153(5):932–8.

    Article  CAS  Google Scholar 

  16. Kibrick S, Takahashi GH, Leibowitz HM, Laibson PR. Local corticosteroid therapy and reactivation of herpetic keratitis. Arch Ophthalmol. 1971;86(6):694–8.

    Article  CAS  Google Scholar 

  17. Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210–20.

    Article  CAS  Google Scholar 

  18. Sharma N, Vajpayee RB, Pushker N, Vajpayee M. Infectious crystalline keratopathy. CLAO J. 2000;26(1):40–3.

    CAS  PubMed  Google Scholar 

  19. Dunne JA, Travers JP. Topical steroids in anterior uveitis. Trans Ophthalmol Soc U K. 1979;99(4):481–4.

    CAS  PubMed  Google Scholar 

  20. Foster CS, Alter G, DeBarge LR, Raizman MB, Crabb JL, Santos CI, et al. Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. Am J Ophthalmol. 1996;122(2):171–82.

    Article  CAS  Google Scholar 

  21. Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol. 1999;127(5):537–44.

    Article  Google Scholar 

  22. Foster CS, Davanzo R, Flynn TE, McLeod K, Vogel R, Crockett RS. Durezol (difluprednate ophthalmic emulsion 0.05%) compared to Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010;26(5):475–83.

    Article  CAS  Google Scholar 

  23. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–16.

    Article  Google Scholar 

  24. Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology. 2010;117(7):1436–41.

    Article  Google Scholar 

  25. Lahdes K, Huupponen R, Kaila T, Salminen L, Iisalo E. Systemic absorption of ocular scopolamine in patients. J Ocul Pharmacol. 1990;6(1):61–6.

    Article  CAS  Google Scholar 

  26. Lahdes K, Kaila T, Huupponen R, Salminen L, Iisalo E. Systemic absorption of topically applied ocular atropine. Clin Pharmacol Ther. 1988;44(3):310–4.

    Article  CAS  Google Scholar 

  27. Lahdes K, Huupponen R, Kaila T, Monti D, Saettone MF, Salminen L. Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations. Br J Clin Pharmacol. 1993;35(5):479–83.

    Article  CAS  Google Scholar 

  28. Lahdes K, Huupponen R, Kaila T, Ali-Melkkilä T, Salminen L, Saari M. Systemic absorption of ocular cyclopentolate in children. Ger J Ophthalmol. 1992;1(1):16–8.

    CAS  PubMed  Google Scholar 

  29. van Minderhout HM, Joosse MV, Grootendorst DC, Schalij-Delfos NE. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study. BMJ Open. 2015;5(12):e008798.

    Article  Google Scholar 

  30. Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology. 1986;93(8):1038–40.

    Article  CAS  Google Scholar 

  31. Wilson DJ, Schutte SM, Abel SR. Comparing the efficacy of ophthalmic NSAIDs in common indications: a literature review to support cost-effective prescribing. Ann Pharmacother. 2015;49(6):727–34.

    Article  CAS  Google Scholar 

  32. Bucolo C, Marrazzo G, Platania CB, Romano GL, Drago F, Salomone S. Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation. J Pharm Pharmacol. 2014;66(7):954–60.

    Article  CAS  Google Scholar 

  33. Sand BB, Krogh E. Topical indometacin, a prostaglandin inhibitor, in acute anterior uveitis. A controlled clinical trial of non-steroid versus steroid anti-inflammatory treatment. Acta Ophthalmol. 1991;69(2):145–8.

    Article  CAS  Google Scholar 

  34. Dunne JA, Jacobs N, Morrison A, Gilbert DJ. Efficacy in anterior uveitis of two known steroids and topical tolmetin. Br J Ophthalmol. 1985;69(2):120–5.

    Article  CAS  Google Scholar 

  35. Lin JC, Rapuano CJ, Laibson PR, Eagle RC, Cohen EJ. Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol. 2000;118(8):1129–32.

    CAS  PubMed  Google Scholar 

  36. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001;99:205–10; discussion 10-2.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. 2001;108(5):936–44.

    Article  CAS  Google Scholar 

  38. Young BJ, Cunningham WF, Akingbehin T. Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol. 1982;66(6):389–91.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA

    Andrew W. Francis & Andrea D. Birnbaum

  2. Department of Ophthalmology, Northwestern University, Chicago, IL, USA

    Andrea D. Birnbaum

Authors
  1. Andrew W. Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea D. Birnbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health and Science University, Casey Eye Institute, Portland, OR, USA

    Phoebe Lin

  2. Oregon Health and Science University, OHSU-PSU School of Public Health, Portland Veterans Administration Medical Center, Portland, OR, USA

    Eric Suhler

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Francis, A.W., Birnbaum, A.D. (2019). Topical Therapy in Uveitis. In: Lin, P., Suhler, E. (eds) Treatment of Non-infectious Uveitis. Springer, Cham. https://doi.org/10.1007/978-3-030-22827-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22827-9_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22825-5

  • Online ISBN: 978-3-030-22827-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation